
Citraript 1.37gm Syrup
Marketer
Kript Pharmaceuticals Private Limited
Salt Composition
Disodium Hydrogen Citrate (1.37gm)
Overview Citraript 1.37gm Syrup
Gout and kidney stone management may involve Citraript 1.37gm Syrup, a medication that inhibits uric acid synthesis, thus lessening gout attacks and the risk of kidney stone formation. Citraript 1.37gm Syrup may be administered with or without food to minimize digestive upset. Consistent use is crucial; discontinue only upon physician advisement. Commonly reported adverse effects include abdominal discomfort, diarrhea, nausea, vomiting, urinary frequency, and fatigue. Persistent or worsening side effects warrant immediate medical attention; dosage adjustment or alternative therapies may be considered. Prior to commencing treatment, inform your physician of all concurrent medications, as well as any pre-existing cardiac, renal, or hepatic conditions. Pregnant or breastfeeding individuals should seek medical counsel before using this medication.
Uses of Citraript 1.37gm Syrup
Managing Gout and Kidney Stones
Major Benefits of Citraript 1.37gm Syrup:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Consult the product label for complete instructions prior to use. Employ a measuring cup for accurate oral administration. Ensure thorough shaking before each dose. Citraript 1.37gm Syrup can be ingested with or without food; however, consistent timing is recommended.
Common Side effects of Citraript 1.37gm Syrup:
- Stomach pain
- Tiredness
- Diarrhea
- Nausea
- Vomiting
- Frequent urge to urinate
How to use Citraript 1.37gm Syrup:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Consult the product label for detailed instructions prior to consumption. Use a measuring cup for accurate dosing and ingest orally. Ensure thorough shaking before each use. Citarript 1.37gm Syrup can be consumed with or without food; however, consistent daily timing is recommended.
How Citraript 1.37gm Syrup works:
Citraript 1.37gm Syrup elevates urinary pH, acting as a urine alkalinizer. This reduction in urine acidity facilitates the renal excretion of excess uric acid, thus mitigating gout and specific kidney stone formations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Citarript 1.37gm Syrup's interaction with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Citraript 1.37gm Syrup use in pregnancy is absent. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Citraript 1.37gm Syrup with breastfeeding is absent. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Driving ability while using Citraript 1.37gm Syrup is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, Citraript 1.37gm Syrup requires careful administration. A modified dosage of Citraript 1.37gm Syrup might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Citraript 1.37gm Syrup to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Citraript 1.37gm Syrup :
Should you forget a Citraript 1.37gm Syrup dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citraript 1.37gm Syrup
| Label | Value |
|---|---|
| Chemical Category | Tricarboxylate Derivative |
| Developing Habits | No. |
| Treatment Category | Urology |
| Action Class | Gout treatment with uricosuric agents |
